Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bixby

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 studyRonan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Cell Reports|April 7, 2016
Enhanced Transcriptional Activity and Mitochondrial Localization of STAT3 Co-induce Axon Regrowth in the Adult Central Nervous SystemXueting Luo, Marcio Ribeiro, Eric R Bray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition With Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild Type Acute Myeloid LeukemiasWeiguo Zhang, Li Li, Muharrem Muftuoglu, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
Leukemia & Lymphoma|April 8, 2021
Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemiaLydia L Benitez, Anthony J Perissinotti, Caitlin R Rausch, et al.
Journal of Neurotrauma|October 15, 2019
FAIR SCI Ahead: The Evolution of the Open Data Commons for Pre-Clinical Spinal Cord Injury ResearchKarim Fouad, John L Bixby, Alison Callahan, et al.
Science (New York, N.Y.)|March 14, 2015
Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injuryJörg Ruschel, Farida Hellal, Kevin C Flynn, et al.
Experimental Neurology|December 8, 2024
Data reporting quality and semantic interoperability increase with community-based data elements (CoDEs). Analysis of the open data commons for spinal cord injury (ODC-SCI)Anushka Sheoran, Kenneth A Fond, Lex Maliga Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2010
A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regenerationLynn C Usher, Andrea Johnstone, Ali Ertürk, et al.
The Lancet. Haematology|June 25, 2021
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trialJeffrey E Lancet, Geoffrey L Uy, Laura F Newell, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 studyRonan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Cell Reports|April 7, 2016
Enhanced Transcriptional Activity and Mitochondrial Localization of STAT3 Co-induce Axon Regrowth in the Adult Central Nervous SystemXueting Luo, Marcio Ribeiro, Eric R Bray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition With Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild Type Acute Myeloid LeukemiasWeiguo Zhang, Li Li, Muharrem Muftuoglu, et al.
Leukemia Research|February 15, 2017
Genomic analysis of adult B-ALL identifies potential markers of shorter survivalShiven Patel, Clinton C Mason, Martha J Glenn, et al.
Leukemia & Lymphoma|April 8, 2021
Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemiaLydia L Benitez, Anthony J Perissinotti, Caitlin R Rausch, et al.
Journal of Neurotrauma|October 15, 2019
FAIR SCI Ahead: The Evolution of the Open Data Commons for Pre-Clinical Spinal Cord Injury ResearchKarim Fouad, John L Bixby, Alison Callahan, et al.
Science (New York, N.Y.)|March 14, 2015
Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injuryJörg Ruschel, Farida Hellal, Kevin C Flynn, et al.
Experimental Neurology|December 8, 2024
Data reporting quality and semantic interoperability increase with community-based data elements (CoDEs). Analysis of the open data commons for spinal cord injury (ODC-SCI)Anushka Sheoran, Kenneth A Fond, Lex Maliga Davis, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2010
A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regenerationLynn C Usher, Andrea Johnstone, Ali Ertürk, et al.
The Lancet. Haematology|June 25, 2021
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trialJeffrey E Lancet, Geoffrey L Uy, Laura F Newell, et al.
Pageof 20